Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

10.89

-1.63 (-13.02%)

At close: May 8, 2026, 4:00 PM EDT

11.50

+0.61 (5.60%)

After-hours: May 8, 2026, 7:59 PM EDT

Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20.96	26.7	40.24	53.5	102.53	160.92
Short-Term Investments	65.83	81.31	145.19	23.47	-	-
Cash & Short-Term Investments	86.78	108.01	185.43	76.97	102.53	160.92
Cash Growth	-47.71%	-41.75%	140.91%	-24.93%	-36.29%	532.51%
Total Current Assets	86.78	108.01	185.43	76.97	102.53	160.92
Total Assets	86.78	108.01	185.43	76.97	102.53	160.92
Net Cash (Debt)	86.78	108.01	185.43	76.97	102.53	160.92
Net Cash Growth	-19.65%	-41.75%	140.91%	-24.93%	-36.29%	532.51%
Net Cash Per Share	3.54	4.42	16.47	95.89	133.73	0.23

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q